Skip to main content
Top
Published in: Aesthetic Plastic Surgery 6/2021

01-12-2021 | Lymphoma | Original Article

Is Breast Implant Associated—Anaplastic Large Cell Lymphoma linked to textured implants?

Authors: Maurizio Bruno Nava, Paolo Chiodini, Giuseppe Catanuto, Nicola Rocco

Published in: Aesthetic Plastic Surgery | Issue 6/2021

Login to get access

Abstract

Abstract

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) is a distinctive type of T-cell lymphoma arising around breast implants. We performed a review of the existing literature with the aim of providing an evidence-based overview of the available data on BIA-ALCL with a standardized evaluation of the quality of the studies and investigating the potential association between textured breast implants and BIA-ALCL.We analyzed the literature reporting estimates of relative or absolute risks of BIA-ALCL in case-control, cohort studies and case series studies. The total number of BIA-ALCL cases reported in literature is very low. Furthermore, most of the reported cases have been reported in case-control studies or case series. This means that our knowledge is based on a low level of evidence. Moreover, low-medium quality scores were observed in the included case series studies. In relation to the rarity of the event, better information could only derived by international cooperation to pool together data deriving from all over the world, with the clear need of better reporting patients and implant characteristics in case series and when adding data to public registries.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
go back to reference Swerdlow AH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390CrossRef Swerdlow AH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390CrossRef
2.
go back to reference Keech JA Jr, Creech BJ (1997) Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 100:554–555CrossRef Keech JA Jr, Creech BJ (1997) Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 100:554–555CrossRef
3.
go back to reference Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T, Connell T, Lofts J, Locke M, Hopper I, Cooter R, Vickery K, Joshi PA, Prince HM, Deva AK (2017) Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 140(4):645–654CrossRef Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T, Connell T, Lofts J, Locke M, Hopper I, Cooter R, Vickery K, Joshi PA, Prince HM, Deva AK (2017) Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 140(4):645–654CrossRef
4.
go back to reference Magnusson M1, Beath K, Cooter R, Locke M, Prince HM, Elder E, Deva AK (2019) The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants. Plast Reconstr Surg 143(5):1285–1292CrossRef Magnusson M1, Beath K, Cooter R, Locke M, Prince HM, Elder E, Deva AK (2019) The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants. Plast Reconstr Surg 143(5):1285–1292CrossRef
5.
go back to reference Loch-Wilkinson A, Beath KJ, Magnusson MR, Cooter R, Shaw K, French J, Vickery K, Prince HM, Deva AK (2020) Breast implant-associated anaplastic large cell lymphoma in Australia: a longitudinal study of implant and other related risk factors. Aesthet Surg J 40(8):838–846CrossRef Loch-Wilkinson A, Beath KJ, Magnusson MR, Cooter R, Shaw K, French J, Vickery K, Prince HM, Deva AK (2020) Breast implant-associated anaplastic large cell lymphoma in Australia: a longitudinal study of implant and other related risk factors. Aesthet Surg J 40(8):838–846CrossRef
6.
go back to reference Cordeiro PG, Ghione P, Ni A, Hu Q, Ganesan N, Galasso N, Dogan A, Horwitz SM (2020) Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg 73(5):841–846CrossRef Cordeiro PG, Ghione P, Ni A, Hu Q, Ganesan N, Galasso N, Dogan A, Horwitz SM (2020) Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg 73(5):841–846CrossRef
8.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG (2009) The PRISMA group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG (2009) The PRISMA group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef
11.
go back to reference Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ EBM 23(2):60–63CrossRef Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ EBM 23(2):60–63CrossRef
12.
go back to reference de Jong D, Vasmel WL, de Boer JP, Verhave G, Barbé E, Casparie MK, Van Leeuwen FE (2008) Anaplastic large-cell lymphoma in women with breast implants. JAMA 300(17):2030–2035CrossRef de Jong D, Vasmel WL, de Boer JP, Verhave G, Barbé E, Casparie MK, Van Leeuwen FE (2008) Anaplastic large-cell lymphoma in women with breast implants. JAMA 300(17):2030–2035CrossRef
13.
go back to reference de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D (2018) Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol 4(3):335–341CrossRef de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D (2018) Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol 4(3):335–341CrossRef
14.
go back to reference Vase MØ, Friis S, Bautz A, Bendix K, Sørensen HT, d’Amore F (2013) Breast implants and anaplastic large-cell lymphoma: a danish population-based cohort study. Cancer Epidemiol Biomarkers Prev 22(11):2126–2129CrossRef Vase MØ, Friis S, Bautz A, Bendix K, Sørensen HT, d’Amore F (2013) Breast implants and anaplastic large-cell lymphoma: a danish population-based cohort study. Cancer Epidemiol Biomarkers Prev 22(11):2126–2129CrossRef
15.
go back to reference Wang SS, Deapen D, Voutsinas J, Lacey JV Jr, Lu Y, Ma H, Clarke CA, Weisenburger D, Forman SJ, Bernstein L (2016) Breast implants and anaplastic large cell lymphomas among females in the California teachers study cohort. Br J Haematol 174(3):480–483CrossRef Wang SS, Deapen D, Voutsinas J, Lacey JV Jr, Lu Y, Ma H, Clarke CA, Weisenburger D, Forman SJ, Bernstein L (2016) Breast implants and anaplastic large cell lymphomas among females in the California teachers study cohort. Br J Haematol 174(3):480–483CrossRef
16.
go back to reference Warschkow R, Cerny T, Schmied BM, Güller U, Thuerlimann B, Joerger M (2016) A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. Br J Cancer 115(1):80–84CrossRef Warschkow R, Cerny T, Schmied BM, Güller U, Thuerlimann B, Joerger M (2016) A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. Br J Cancer 115(1):80–84CrossRef
17.
go back to reference Campanale A, Boldrini R, Marletta M (2018) 22 Cases of breast implant-associated ALCL: awareness and outcome tracking from the Italian ministry of health. Plast Reconstr Surg 141(1):11e–19eCrossRef Campanale A, Boldrini R, Marletta M (2018) 22 Cases of breast implant-associated ALCL: awareness and outcome tracking from the Italian ministry of health. Plast Reconstr Surg 141(1):11e–19eCrossRef
18.
go back to reference Campanale A, Spagnoli A, Lispi L, Boldrini R, Marletta M (2020) The crucial role of surgical treatment in BIA-ALCL prognosis in early- and advanced-stage patients. Plast Reconstr Surg 146(5):530e–538eCrossRef Campanale A, Spagnoli A, Lispi L, Boldrini R, Marletta M (2020) The crucial role of surgical treatment in BIA-ALCL prognosis in early- and advanced-stage patients. Plast Reconstr Surg 146(5):530e–538eCrossRef
19.
go back to reference Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, Butler CE, Clemens MWUS (2017) Epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 139(5):1042–1050CrossRef Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, Butler CE, Clemens MWUS (2017) Epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 139(5):1042–1050CrossRef
20.
go back to reference Largent J, Oefelein M, Kaplan HM, Okerson T, Boyle P (2012) Risk of lymphoma in women with breast implants: analysis of clinical studies. Eur J Cancer Prev 21(3):274–280CrossRef Largent J, Oefelein M, Kaplan HM, Okerson T, Boyle P (2012) Risk of lymphoma in women with breast implants: analysis of clinical studies. Eur J Cancer Prev 21(3):274–280CrossRef
21.
go back to reference Adams WP Jr, Culbertson EJ, Deva AK, Magnusson MR, Layt C, Jewell ML, Mallucci P, Hedén P (2017) Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants. Plast Reconstr Surg 140(3):427–431CrossRef Adams WP Jr, Culbertson EJ, Deva AK, Magnusson MR, Layt C, Jewell ML, Mallucci P, Hedén P (2017) Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants. Plast Reconstr Surg 140(3):427–431CrossRef
22.
go back to reference Singh N, Picha GJ, Hardas B, Schumacher A, Murphy DK (2017) Five-year safety data for more than 55,000 subjects following breast implantation: comparison of rare adverse event rates with silicone implants versus national norms and saline implants. Plast Reconstr Surg 140(4):666–679CrossRef Singh N, Picha GJ, Hardas B, Schumacher A, Murphy DK (2017) Five-year safety data for more than 55,000 subjects following breast implantation: comparison of rare adverse event rates with silicone implants versus national norms and saline implants. Plast Reconstr Surg 140(4):666–679CrossRef
23.
go back to reference McGuire P, Reisman NR, Murphy DK (2017) Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg 139(1):1–9CrossRef McGuire P, Reisman NR, Murphy DK (2017) Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg 139(1):1–9CrossRef
24.
go back to reference Clemens MW, McGuire PA (2019) Discussion: a prospective approach to inform and treat 1340 patients at risk for BIA-ALCL. Plast Reconstr Surg 144(1):57–59CrossRef Clemens MW, McGuire PA (2019) Discussion: a prospective approach to inform and treat 1340 patients at risk for BIA-ALCL. Plast Reconstr Surg 144(1):57–59CrossRef
25.
go back to reference Coroneos CJ, Selber JC, Offodile AC 2nd, Butler CE, Clemens MW (2019) US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients. Ann Surg 269(1):30–36CrossRef Coroneos CJ, Selber JC, Offodile AC 2nd, Butler CE, Clemens MW (2019) US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients. Ann Surg 269(1):30–36CrossRef
26.
go back to reference Caplin DA (2014) Indications for the use of MemoryShape breast implants in aesthetic and reconstructive breast surgery: long-term clinical outcomes of shaped versus round silicone breast implants. Plast Reconstr Surg 134(3 Suppl):27S-37SCrossRef Caplin DA (2014) Indications for the use of MemoryShape breast implants in aesthetic and reconstructive breast surgery: long-term clinical outcomes of shaped versus round silicone breast implants. Plast Reconstr Surg 134(3 Suppl):27S-37SCrossRef
27.
go back to reference Maxwell GP, Van Natta BW, Bengtson BP, Murphy DK (2015) Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study. Aesthet Surg J 35(2):145–155CrossRef Maxwell GP, Van Natta BW, Bengtson BP, Murphy DK (2015) Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study. Aesthet Surg J 35(2):145–155CrossRef
28.
go back to reference Spear SL, Murphy DK (2014) Allergan silicone breast implant U.S. core clinical study group natrelle round silicone breast implants: core study results at 10 years. Plast Reconstr Surg 133(6):1354–1361CrossRef Spear SL, Murphy DK (2014) Allergan silicone breast implant U.S. core clinical study group natrelle round silicone breast implants: core study results at 10 years. Plast Reconstr Surg 133(6):1354–1361CrossRef
29.
go back to reference Grant Stevens W, Calobrace MB, Harrington J, Alizadeh K, Zeidler KR, d’Incelli RC (2016) Nine-Year core study data for sientra’s fda-approved round and shaped implants with high-strength cohesive silicone gel. Aesthet Surg J 36(4):404–416CrossRef Grant Stevens W, Calobrace MB, Harrington J, Alizadeh K, Zeidler KR, d’Incelli RC (2016) Nine-Year core study data for sientra’s fda-approved round and shaped implants with high-strength cohesive silicone gel. Aesthet Surg J 36(4):404–416CrossRef
30.
go back to reference Hammond DC, Canady JW, Love TR, Wixtrom RN, Caplin DA (2017) Mentor contour profile gel implants: clinical outcomes at 10 Years. Plast Reconstr Surg 140(6):1142–1150CrossRef Hammond DC, Canady JW, Love TR, Wixtrom RN, Caplin DA (2017) Mentor contour profile gel implants: clinical outcomes at 10 Years. Plast Reconstr Surg 140(6):1142–1150CrossRef
31.
go back to reference Rastogi P, Riordan E, Moon D, Deva AK (2019) Theories of etiopathogenesis of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 143:23S-29SCrossRef Rastogi P, Riordan E, Moon D, Deva AK (2019) Theories of etiopathogenesis of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 143:23S-29SCrossRef
34.
go back to reference Barnsley GP, Sigurdson LJ, Barnsley SE (2006) Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 117:2182–2190CrossRef Barnsley GP, Sigurdson LJ, Barnsley SE (2006) Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 117:2182–2190CrossRef
35.
go back to reference Wong CH, Samuel M, Tan BK et al (2006) Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 118:1224–1236CrossRef Wong CH, Samuel M, Tan BK et al (2006) Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 118:1224–1236CrossRef
36.
go back to reference Srinivasa DR, Miranda RN, Kaura A, Francis AM, Campanale A, Boldrini R, Alexander J, Deva AK, Gravina PR, Medeiros LJ, Nast K, Butler CE, Clemens MW (2017) Global adverse event reports of breast implant-associated ALCL: an international review of 40 government authority databases. Plast Reconstr Surg. 139(5):1029–1039CrossRef Srinivasa DR, Miranda RN, Kaura A, Francis AM, Campanale A, Boldrini R, Alexander J, Deva AK, Gravina PR, Medeiros LJ, Nast K, Butler CE, Clemens MW (2017) Global adverse event reports of breast implant-associated ALCL: an international review of 40 government authority databases. Plast Reconstr Surg. 139(5):1029–1039CrossRef
37.
go back to reference Clemens MW, Medeiros LJ, Butler CE et al (2016) Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Onc. 34(2):160–168CrossRef Clemens MW, Medeiros LJ, Butler CE et al (2016) Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Onc. 34(2):160–168CrossRef
38.
go back to reference Brody GS, Deapen D, Taylor CR, Pinter-Brown L, House-Lightner SR, Andersen JS, Carlson G, Lechner MG, Epstein AL (2015) Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 135(3):695–705CrossRef Brody GS, Deapen D, Taylor CR, Pinter-Brown L, House-Lightner SR, Andersen JS, Carlson G, Lechner MG, Epstein AL (2015) Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 135(3):695–705CrossRef
39.
go back to reference Laurent C, Delas A, Gaulard P (2016) Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 27(2):306–314CrossRef Laurent C, Delas A, Gaulard P (2016) Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 27(2):306–314CrossRef
40.
go back to reference Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK (2019) Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 143:30S-40SCrossRef Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK (2019) Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 143:30S-40SCrossRef
42.
go back to reference Lee KT, Kim S, Jeon BJ, Pyon JK, Mun GH, Ryu JM, Lee SK, Yu J, Kim SW, Lee JE, Nam SJ, Bang SI (2020) Association of the implant surface texture used in reconstruction with breast cancer recurrence. JAMA Surg. 7:e204124 Lee KT, Kim S, Jeon BJ, Pyon JK, Mun GH, Ryu JM, Lee SK, Yu J, Kim SW, Lee JE, Nam SJ, Bang SI (2020) Association of the implant surface texture used in reconstruction with breast cancer recurrence. JAMA Surg. 7:e204124
43.
go back to reference Shen Z, Sun J, Yu Y, Chiu C, Zhang Z, Zhang Y, Xu J (2020) Oncological safety and complication risks of mastectomy with or without breast reconstruction: a bayesian analysis. J Plast Reconstr Aesthet Surg. S1748–6815(20):30428–30429 Shen Z, Sun J, Yu Y, Chiu C, Zhang Z, Zhang Y, Xu J (2020) Oncological safety and complication risks of mastectomy with or without breast reconstruction: a bayesian analysis. J Plast Reconstr Aesthet Surg. S1748–6815(20):30428–30429
Metadata
Title
Is Breast Implant Associated—Anaplastic Large Cell Lymphoma linked to textured implants?
Authors
Maurizio Bruno Nava
Paolo Chiodini
Giuseppe Catanuto
Nicola Rocco
Publication date
01-12-2021
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 6/2021
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-021-02260-0

Other articles of this Issue 6/2021

Aesthetic Plastic Surgery 6/2021 Go to the issue